BNP Paribas Financial Markets Lowers Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

BNP Paribas Financial Markets lessened its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 94.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 16,189 shares of the company's stock after selling 265,031 shares during the quarter. BNP Paribas Financial Markets' holdings in Acadia Healthcare were worth $642,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Ameriprise Financial Inc. grew its holdings in Acadia Healthcare by 209.0% in the fourth quarter. Ameriprise Financial Inc. now owns 431,225 shares of the company's stock worth $17,098,000 after purchasing an additional 291,671 shares during the period. Algert Global LLC purchased a new stake in Acadia Healthcare in the fourth quarter worth about $334,000. Aryeh Capital Management Ltd. purchased a new stake in Acadia Healthcare in the fourth quarter worth about $10,860,000. Caisse DE Depot ET Placement DU Quebec purchased a new stake in Acadia Healthcare in the fourth quarter worth about $4,480,000. Finally, Freestone Grove Partners LP purchased a new stake in Acadia Healthcare in the fourth quarter worth about $29,943,000.

Wall Street Analysts Forecast Growth

ACHC has been the topic of a number of recent research reports. Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. Barclays decreased their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a report on Wednesday, May 14th. Royal Bank of Canada decreased their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Bank of America decreased their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a report on Friday, February 28th. Finally, Mizuho decreased their target price on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a report on Wednesday, May 14th. Four analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $47.94.

Acadia Healthcare Stock Performance

Shares of ACHC traded up $0.10 during mid-day trading on Thursday, hitting $22.85. 944,005 shares of the company traded hands, compared to its average volume of 1,717,779. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The stock has a 50-day moving average price of $25.21 and a two-hundred day moving average price of $34.43. Acadia Healthcare Company, Inc. has a 1 year low of $20.36 and a 1 year high of $82.41. The stock has a market cap of $2.10 billion, a price-to-earnings ratio of 7.49, a P/E/G ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. During the same period in the previous year, the business posted $0.84 earnings per share. The firm's quarterly revenue was up .3% compared to the same quarter last year. Equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.